Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Gokshuradi Guggulu

Ayurvedic Gokshura (Tribulus) + Guggulu Urogenital Formula

Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Not FDA approved; sold as a dietary supplement / Ayurvedic product

Reference only. Not medical advice.

What can go wrong

Guggulu can cause GI upset, skin rash and may interact with thyroid medication and anticoagulants; it is generally avoided in pregnancy. Gokshuradi guggulu is a herbal formula (no mercurials in the classic recipe), but the broader Ayurvedic market has documented heavy-metal contamination, so third-party purity testing matters. Single-herb Tribulus has also been linked to rare hepatotoxicity case reports at high doses. Sexual-benefit claims are not trial-supported.

This is something to take to a clinician. The Atlas can tell you what is known about gokshuradi guggulu in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Gokshuradi Guggulu is a classical Ayurvedic guggulu formula (described in Sharangadhara Samhita and Bhaishajya Ratnavali) combining gokshura (Tribulus terrestris) with guggulu resin (Commiphora mukul), triphala, trikatu (pippali, black pepper, ginger) and musta (Cyperus rotundus). It is primarily a urinary-tract and joint formula, traditionally used for dysuria, urinary calculi, UTIs and gout, and secondarily framed as a male reproductive tonic because gokshura is a classical vrishya (aphrodisiac) herb. It is distinct from single-herb Tribulus supplements: the guggulu matrix and diuretic/lithotriptic intent dominate. Sexual-function evidence for the finished formula is minimal.

The gokshura-guggulu urinary-tract classic, distinct from single-herb Tribulus marketing.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Dysuria, UTI, urinary calculi (traditional/primary)
  • Gout and joint pain (traditional)
  • Male reproductive/urogenital tonic (traditional)
  • Sperm quality support (claimed)

How it is supposed to work

Gokshura contains steroidal saponins and alkaloids credited with diuretic and lithotriptic action; guggulu resin contributes anti-inflammatory guggulsterones; trikatu is used to enhance bioavailability. The urinary-tract rationale is more coherent than the sexual one. Tribulus itself has repeatedly failed to raise testosterone convincingly in humans, so any virility claim rests on weak ground.

What people get wrong

  • Often saidTribulus formula that raises testosterone and potency

    ActuallyHuman trials of Tribulus generally fail to show meaningful testosterone or erectile benefit; Gokshuradi Guggulu is primarily a urinary-tract formula, not a proven virility booster.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

How we got here

As a guggulu-class formula it belongs to the medieval Ayurvedic pharmacopeia (Sharangadhara Samhita, ~13th century) and later compendia, positioned mainly for mutravaha srotas (urinary channel) disorders. Modern Ayurvedic brands (Banyan Botanicals, Himalaya, Baidyanath and others) sell it for urinary and prostate/reproductive support.

At a glance

Key herbs
Gokshura + guggulu + triphala + trikatu + musta
Texts
Sharangadhara Samhita; Bhaishajya Ratnavali
Primary use
Urinary tract / calculi
Tribulus role
Diuretic + classical aphrodisiac

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Gokshuradi Guggulu. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.

Sources

No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.